|Day Low/High||196.69 / 199.56|
|52 Wk Low/High||161.29 / 206.63|
Jim Cramer says history doesn't have to repeat itself. You don't want to miss another opportunity in the highly visible FANG-style stocks.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Becton, Dickinson & Co has taken over the #93 spot from Parker Hannifin Corp , according to ETF Channel. Below is a chart of Becton, Dickinson & Co versus Parker Hannifin Corp plotting their respective rank within the S&P 500 over time (BDX plotted in blue; PH plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
The S&P 500 has returned 10% year to date, while the top half of it, around 16%.
Jim Cramer calls Baxter International, Becton Dickinson, and Boston Scientific the 'Killer Bs'.
Jim Cramer says he wishes Washington would just focus on repatriation and get a win for the U.S. economy and markets.
Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.
FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data, and global medical technology company, BD (Becton, Dickinson and Company) (NYSE:BDX),...
The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 1,187,170 share increase in total short interest for Becton, Dickinson & Co , to 11,603,221, an increase of 11.40% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Recognized for 3D interactive customer engagement applications developed for GE Healthcare and Becton Dickinson Diagnostics
Jim Cramer is bullish on Walgreens Boots Alliance, Becton Dickinson, and General Mills.
Money managers are piling back into growth stocks without hesitation, says Jim Cramer.
But investors should not take that as a sign it's a good idea to hedge by buying the VIX.
May kicks off with a busy first week filled with earnings, monetary policy and a snapshot of the health of the economy.
Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.
A vote for the status quo lights a fire under European markets, which translates to a great day for Wall Street.
Let's play out what's allowing our markets to fly: Earnings.